A detailed history of Graham Capital Management, L.P. transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 21,137 shares of STRO stock, worth $39,103. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,137
Holding current value
$39,103
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.88 - $5.01 $60,874 - $105,896
21,137 New
21,137 $73,000
Q2 2022

Aug 15, 2022

BUY
$3.41 - $8.95 $859,050 - $2.25 Million
251,921 New
251,921 $1.31 Million

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $96.5M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.